Biocon facility receives inspection closure report from USFDA
Biocon has received the Establishment Inspection Report, from the USFDA with voluntary action indicated status, on closure of inspection of its aseptic drug product facility....
Tag : Biocon
Biocon receives CRL for anti cancer drug, from USFDA
As per Biocon, the US health regulator has issued complete response letter (CRL) for proposed biosimilar Pegfilgrastim, which is to be used in treatment for...
Biocon reports 51% decline in net profit at Rs 81 crore in Q1
Biocon has posted a net decrease of 51 percent for the quarter ended June. The company that posted a net profit of Rs 81 crore...
Biocon and Quark has received DCGI approval for trials of new eye disease drug
Biocon, the bio pharmaceutical firm and its partner Quark Pharmaceuticals has received the Drug Controller General of India (DCGI)’s approval to proceed with clinical trials...
Biocon Q2 net profit increases to Rs 306 crore
On Tuesday, the Biotechnology major Biocon has posted an increases in its consolidated net profit at Rs 306 crore for the second quarter ended September...
Biocon files prospectus with SEBI for Syngene IPO
The company has filed prospectus with the capital market regulator SEBI for the initial public offer of its research arm Syngene on Wednesday. The company...